NewAmsterdam Pharma N.V. (NAMSW)
NASDAQ: NAMSW
· Real-Time Price · USD
8.64
-0.70 (-7.49%)
At close: May 06, 2025, 10:44 AM
8.64
0.00%
After-hours: May 06, 2025, 04:00 PM EDT
-7.49% (1D)
| Bid | 8.51 |
| Market Cap | 2.05B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 9.7 |
| Volume | 240 |
| Avg. Volume (20D) | 3,218 |
| Open | 8.64 |
| Previous Close | 9.34 |
| Day's Range | 8.64 - 8.64 |
| 52-Week Range | 5.45 - 16.75 |
| Beta | 0.01 |
About NAMSW
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein ...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 10, 2021
Employees 68
Stock Exchange NASDAQ
Ticker Symbol NAMSW